Good Intentionsis a tale of vaulting ambition, greed,
and hubris set against the tragic backdrop of the world's number-one health
Bruce Nussbaum takes us behind the scenes to reveal how America's top
scientists are at the center of a triangle of power. He shows how the National
Institute of Health allied with the drug company Burroughs Wellcome, secretly
helped by the FDA, to steamroll a thirty-year-old drug, AZT, into becoming
the only approved treatment for AIDS.
At the heart of the story is a small group of scientists that hold the
lives of tens of thousands in their hands. There's the puppet master, the
brilliant Dr. David Barry, Burroughs Wellcome's chief strategist; Dr. Tony
Fauci, who grabbed control of the government's AIDS research program only
to squander $1 billion without developing a single new drug; and Michael
Callen, who fought for his life by battling the research labyrinth with
a new biomedical underground.
An old-boy network of powerful medical researchers dominates in every
disease field, from AIDS to Alzheimer's, Nussbaum reports. They control
the major committees, they run the most important trials. They are accountable
to no one. Despite the billions of taxpayers' dollars that go to them every
year, there is no public oversight. Medical scientists have convinced society
that only they can police themselves.
Business Week senior writer Bruce Nussbaum follows the money trial from
the billions appropriated by Congress through a network of government laboratories
and into the profit statements of Burroughs Wellcome. This is an inside
look at how politics, science, and big business are bungling the fight
An award-winning writer, Bruce Nussbaum served in the Peace Corps
from 1967 to 1969. Currently senior writer at Business Week, he is also
the author of The World After Oil: The Shifting Axis of Power and Wealth.
Mr. Nussbaum is married and lives in New York City.